Table 2.
Sociodemographic Characteristics of the Study Subjects
| Characteristics | Study subjectsan = 157 |
|---|---|
| Gender | |
| female | 93 (59.2%) |
| male | 64 (40.8%) |
| Age (years) | |
| ≤45 | 37 (23.6%) |
| >45 | 120 (76.4%) |
| Job type | |
| manual worker | 37 (25.9%) |
| office worker | 66 (46.2%) |
| other | 40 (28.0%) |
| Job experience (years) | |
| ≤15 | 48 (38.1%) |
| >15 | 78 (61.9%) |
| Ethnic group | |
| African American | 37 (23.6%) |
| Caucasian | 108 (68.8%) |
| Asian, Native, other | 12 (7.6%) |
| Education level | |
| high school or less | 117 (74.5%) |
| college, university | 40 (25.5%) |
| SMBG frequency (times/last week) | |
| ≤20 | 69 (43.9%) |
| >20 | 88 (56.1%) |
| Average SMBG frequency (times/day) | |
| ≤3 | 83 (52.9%) |
| >3 | 74 (47.1%) |
| SMBG experience (years) | |
| ≤5 | 52 (33.1%) |
| >5 | 105 (66.9%) |
| BG monitoring system normally used | |
| Accu-Chek (Roche) | 23 (18.0%) |
| Ascensia (Bayer) | 11 (8.6%) |
| FreeStyle (Abbott) | 21 (16.4%) |
| OneTouch (LifeScan) | 51 (39.8%) |
| other | 22 (17.2%) |
| Lancing device normally used | |
| Accu-Chek (Roche) | 17 (18.5%) |
| Ascensia (Bayer) | 8 (8.7%) |
| FreeStyle (Abbott) | 16 (17.4%) |
| OneTouch (LifeScan) | 35 (38.0%) |
| other | 16 (17.4%) |
| Lancing site normally used | |
| finger | 151 (96.8%) |
| arm or leg | 5 (3.2%) |
| Insulin therapy | 83 (52.9%) |
| Corrective eye glasses or contact lenses | 120 (76.9%) |
a
Data are valid n (%). Data are from the entry questionnaires.